🔗 Share this article

An underground economy for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Drug Gaining Popularity Online

Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing properties. Followers are urged to message these profiles directly for supplier links, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with thousands of members share comparison images, administration instructions and claims of rapid UK delivery. Vendors promote the drug there before directing customers to other platforms for transactions.

Understanding Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Voice Worries

However, physicians and chemists have warned that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could lead to users administering substances of uncertain source.

Some experts said the popularity for retatrutide could be connected to the rising cost of approved slimming products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to fines, prosecution or prison.

Service Response and Content Removal

Based on TikTok, the platform has taken down violative material and prohibited related hashtags and query recommendations. The company stated it was committed to maintaining the service secure and investing in enhancing enforcement strategies.

Online Marketplace Operations

Investigations also found groups with up to nine thousand members marketing retatrutide using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, filled with images of weight loss, glowing testimonials and step-by-step instructions for mixing or injecting at home.

After minutes of joining one group, a seller shared WhatsApp details, where the majority of purchases occur. The vendor sent an guidebook and promised shipping within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about weight, health issues or previous experience.

Item Details and Costs

Within these communities, messages display black plastic parcels with postal service labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with sterile water, or ready-to-use injectors usually sold at £160 for 20mg. When questioned how long a pen should be used, sellers give conflicting responses varying between a several days to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service said it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting materials they can’t verify. Even if the research behind retatrutide is sound, these online products may not contain what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are using online platforms. But fake treatments are extremely risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.

Her staff has previously encountered patients injured by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may subject patients to possibly serious health risks”.